Indivior Share Discussion Threads

[steeplejack] 25/7/2020 09:51

Today 00:36Indivior Still Faces Uncertain Future Despite US Case End - Moody'sFri, 24th Jul 2020 21:38Alliance News(Alliance News) - Indivior PLC still faces uncertainties, but Moody's Investors Service on Friday said the conclusion of a criminal case in the US was a step in the right direction.The ratings agency affirmed the pharmaceutical firm's B3 corporate family rating and upgraded its probability of default rating to B3-PD from Caa1-PD.The outlook on these ratings was lifted to stable from negative.Indivior on Friday said it will part with USD600 million to resolve criminal charges in the US related to its Suboxone film to treat opioid dependence medication.The company in April 2019 said a grand jury in the Western District of Virginia has issued an indictment of 28 felony counts against the company related to fraud.The felonies, issued in connection with a federal criminal investigation initiated by the US Department of Justice in 2013, include one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and 22 counts of wire fraud.Indivior could have faced USD3 billion in fines related to the matters."Moody's views the settlement a credit negative, as settlement payments will consume cash over several years. Partially offsetting these cash outflows related to the settlement is Indivior's significant cash balance of more than USD900 million," Moody's said."Supporting the outlook revision to stable is Moody's view that Indivior's DOJ settlement payments will be manageable with Indivior's significant cash balances. Moody's expects that Indivior's cash is sufficient to support strategic investments for the ongoing commercialisation of Sublocade and Perseris over the next 18 months, and a working capital unwind associated with sales rebates and returns within Medicaid."Indivior still faces "key uncertainties to the future of its business", the ratings agency said."Successful uptake of its newer products, Sublocade and Perseris, is critical for more than offsetting erosion of its Suboxone Film product to generic competition. Commercial success in both of these products will require significant investment which risk EBITDA running negative over the next 12 to 18 months," Moody's added.Indivior shares closed 38% higher at 119.60 pence each in London on Friday.

[the stigologist] 24/7/2020 20:17

INDV chart is nice but not sure how it becomes a £5 stock again without a new blockbuster (INDV2000 /C4X3256 ?)

[the stigologist] 24/7/2020 19:42

Incredible chart this

Finally after 2 years C4XD have broken above the 200 day Moving Average and broken a long medium term downtrend

There's a gap from c.20p to 40p that needs filling

This could and should go vertical in coming weeks

It has totally missed UK biotech boom because the market was so worried that their one licensee Indivior would be 1) made bankrupt and/or 2) not be allowed to sell through US Government programmes

Both those threats taken off the table

INDV could easily make the decision that it makes sense for them to buy C4XD for £40m or £60m or £80m and thus save themselves $294m in licence milestones and royalties

Meanwhile C4XD like EVG have a NRF2 compound which is highly promising along with an IL17 one. Both could be licenced by bigger biotechs/pharmas to be taken into clinic

[steeplejack] 24/7/2020 16:27

Yes that's certainly true,Sublocade now moves back centre stage.

[gregmorg] 24/7/2020 16:20

Certainly if it hangs around at this price then it seems to me that someone will take it off us! Possibly the Company need some better Sublocade sales to complete the circle.

[hodhasharon] 24/7/2020 16:08

300p target

[steeplejack] 24/7/2020 16:06

Having more nuclear weapons that anyone else is good as a starter.

[the stigologist] 24/7/2020 16:05

INDV could now buy out C4XD

C4XD Market Cap £15m but they have a $294m deal with INDV

Why would INDV pay out $294m when they could easily just pay a 200% premium for C4XD and take it out now for say £45m !

[steeplejack] 24/7/2020 16:03

Interesting that the fine is going to paid slowly but surely over a number of years.Now it's just a question of whether the company can make any money.Of course,now the case has been settled,an element of bid premium can be factored back in or is that wishful thinking :)

[waldron] 24/7/2020 16:02

Price (GBX)
130.00 49.86%

Open / Last close
- / 86.75

High / Low
135.40 / 83.35

Bid / Offer
128.50 / 131.70

[davidlloyd] 24/7/2020 15:59

Well - that should put it into the weekend press 😀.
Good news at last and removal of the major uncertainty that has been hanging over this share.glah.
DL

[pngasef] 24/7/2020 15:58

How come Americans can bully and impose massive fines on British companies but it doesn't work the other way round?? Aren't the Americans supposed to be our friends and the Chinese our enemies???

[waldron] 24/7/2020 15:57

$$$$$$$$$$$$$ WE ARE HERE $$$$$$$$$$$$$$$

110 to 120p

[adrian j boris] 24/7/2020 15:50

Indivior Shares Surge Nearly 60% As It Resolves US Criminal Charges

Fri, 24th Jul 2020 15:41
Alliance News

(Alliance News) - Pharmaceuticals firm Indivior PLC on Friday said it will part with USD600 million to resolve criminal charges in the US related to its Suboxone film opioid dependence medication.

Indivior shares surged 59% to 137.60 pence each in London on Friday afternoon.

The company in April 2019 said a grand jury in the Western District of Virginia has issued an indictment of 28 felony counts against the company related to fraud.

The felonies, issued in connection with a federal criminal investigation initiated by the US Department of Justice in 2013, include one count of conspiracy to commit mail, wire and health care fraud; one count of health care fraud; four counts of mail fraud; and 22 counts of wire fraud.

Indivior could have faced USD3 billion in fines related to the matters.

"Indivior Solutions Inc, a wholly-owned subsidiary of Indivior PLC, has pleaded guilty to one count of making a false statement relating to health care matters in 2012," the company said Friday.

"Indivior will make payments to federal and state authorities totaling USD600 million over a period of seven years."

Indivior Solutions will now be excluded from participating in US government health schemes, though this ban will not affect other Indivior subsidiaries.

"We are pleased to achieve this resolution and move forward in a way that provides certainty for our business in respect of this matter and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world," said Indivior Chief Executive Officer Mark Crossley.

"The incident to which the agreement relates occurred well in the past and does not reflect the values Indivior has strived to demonstrate and uphold during our long history of partnering with healthcare providers, policymakers, and communities to fight the opioid crisis."

By Eric Cunha; [e-mail]

[gregmorg] 24/7/2020 15:50

Steeplejack , This should run a bit from here. The the initial reaction is rather tepid in the circumstances. Not that I play the short term.

[the stigologist] 24/7/2020 15:41

C4XD should be big winners

C4XD licencsing deal with Indivior for $294m

C4XD Mkt Cap just £15m !


Now C4XD can get PAID !

[newtoaim] 24/7/2020 15:38

Dnt gt spiked

[steeplejack] 24/7/2020 15:37

The shining bloody beacon and they won't make a price online!

[gregmorg] 24/7/2020 15:35

Ah, some light at the end of the tunnel! ! !

[the stigologist] 22/7/2020 23:05

Does seem about bloody time they released Information relevant to Investors

GLOBAL MEDIA CONTACTS
Email: [e-mail]
Phone: [phone]

UK Media Contacts

Tulchan Communications LLP
85 Fleet Street
London
EC4Y 1AE
[e-mail]
Phone: [phone]


Been two weeks since they started recruiting

[waldron] 22/7/2020 19:01

Upcoming Events

The information provided below is provisional and subject to change. Details of each event, including venue information, will be confirmed shortly before they are due to take place.

First Half and Second Quarter 2020 Financial Results on July 30th


8 DAYS AND COUNTING